Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

Research into chemical discovery, testing optimization and analysis can be a labor-intensive and time-consuming process. With ...

The US federal agency responsible for regulating medicines wants to speed up the evaluation process using the cderGPT ...

CRISPR Therapeutics benefits from Casgevy’s approval and a deep pipeline, despite early rollout hurdles and cost challenges.

Top-line results from two pivotal Phase III trials found that MR-107A-02 significantly reduced pain intensity following ...

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.

While significant progress has been made in developing treatments for rare diseases—highlighted by the approval of over 800 drugs for orphan diseases since ...

Despite the failures, ALX Oncology remains hopeful about evorpacept and is focusing on combination trials with other ...

ALX On­col­o­gy’s ef­forts to progress a CD47 com­bo hit a ma­jor speed bump.

n today's interconnected world, the future of drug safety and accessibility hinges on proactive regulatory leadership. Indonesia, through the Food and Drug Monitoring Agency (BPOM), is not merely ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...